关注
Jeffrey L Furman
Jeffrey L Furman
在 bu.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The determinants of national innovative capacity
JL Furman, ME Porter, S Stern
Research policy 31 (6), 899-933, 2002
42482002
Catching up or standing still?: National innovative productivity among ‘follower’countries, 1978–1999
JL Furman, R Hayes
Research policy 33 (9), 1329-1354, 2004
5002004
Climbing atop the shoulders of giants: The impact of institutions on cumulative research
JL Furman, S Stern
American Economic Review 101 (5), 1933-1963, 2011
4812011
Governing knowledge in the scientific community: Exploring the role of retractions in biomedicine
JL Furman, K Jensen, F Murray
Research Policy 41 (2), 276-290, 2012
2022012
Firm performance and state innovation funding: Evidence from China’s Innofund program
Y Wang, J Li, JL Furman
Research Policy 46 (6), 1142-1161, 2017
1742017
Public & private spillovers, location and the productivity of pharmaceutical research
JL Furman, M Kyle, IM Cockburn, R Henderson
National Bureau of Economic Research, 2006
1742006
Academic science and the birth of industrial research laboratories in the US pharmaceutical industry
JL Furman, MJ MacGarvie
Journal of Economic Behavior & Organization 63 (4), 756-776, 2007
165*2007
An NCI perspective on creating sustainable biospecimen resources
J Vaught, J Rogers, K Myers, MD Lim, N Lockhart, H Moore, S Sawyer, ...
Journal of the national cancer institute monographs 2011 (42), 1-7, 2011
1382011
Retractions
P Azoulay, JL Furman, F Murray, JL Krieger
Review of Economics and Statistics 97 (5), 1118-1136, 2015
1332015
Disclosure and subsequent innovation: Evidence from the patent depository library program
JL Furman, M Nagler, M Watzinger
American Economic Journal: Economic Policy 13 (4), 239-270, 2021
842021
Automation, research technology, and researchers’ trajectories: Evidence from computer science and electrical engineering
JL Furman, F Teodoridis
Organization Science 31 (2), 330-354, 2020
78*2020
Academic collaboration and organizational innovation: the development of research capabilities in the US pharmaceutical industry, 1927–1946
JL Furman, M MacGarvie
Industrial and Corporate Change 18 (5), 929-961, 2009
752009
Safeguarding the bioeconomy
National Academies of Sciences, Division on Engineering, ...
National Academies Press, 2020
742020
Growing stem cells: The impact of federal funding policy on the US scientific frontier
JL Furman, F Murray, S Stern
Journal of Policy Analysis and Management 31 (3), 661-705, 2012
73*2012
Location and organizing strategy: Exploring the influence of location on the organization of pharmaceutical research
JL Furman
Geography and strategy 20, 49-87, 2003
502003
Turnarounds
JL Furman, AM McGahan
Managerial and Decision Economics 23 (4‐5), 283-300, 2002
402002
Understanding the Drivers of National Innovative Capacity.
JL Furman, ME Porter, S Stern
Academy of management proceedings 2000 (1), A1-A6, 2000
392000
Essays on the role of location in strategy
JL Furman
Massachusetts Institute of Technology, 2001
37*2001
Los factores impulsores de la capacidad innovadora nacional: implicaciones para España y América Latina
ME Porter, JL Furman, S Stern
Claves de la economía mundial 1, 78-88, 2000
30*2000
More for the research dollar
JL Furman, F Murray, S Stern
Nature 468 (7325), 757-758, 2010
152010
系统目前无法执行此操作,请稍后再试。
文章 1–20